化生性乳腺癌的研究进展
Research Progress on Metaplastic Breast Cancer
DOI: 10.12677/acm.2025.153742, PDF,   
作者: 邓求生*：承德医学院研究生院，河北 承德；韩 猛#：秦皇岛市第一医院乳腺外科，河北 秦皇岛
关键词: 乳腺癌；化生性癌；治疗；预后；Breast Cancer； Metaplastic Carcinoma； Treatment； Prognosis
摘要: 化生性乳腺癌(Metaplastic Breast Cancer, MBC)是乳腺癌的一种极少见亚型，发病率极低。化生性乳腺癌影像学可表现为类似良性肿物，鉴别诊断困难，病理学是诊断MBC的金标准。文章详细介绍了该疾病的流行病学特点、病理学分类、临床表现、诊断方法以及治疗策略。同时，探讨了当前治疗面临的挑战和未来研究方向，旨在为临床医生提供全面的诊疗参考。
Abstract: Metaplastic breast cancer (MBC) is a rare subtype of breast cancer with a very low incidence. Metaplastic breast cancer imaging may present as a similar benign mass, differential diagnosis is difficult, and pathology is the gold standard for the diagnosis of MBC. In this paper, the epidemiological characteristics, pathological classification, clinical manifestations, diagnostic methods, and treatment strategies for the disease are introduced in detail. At the same time, the challenges faced by current treatment and future research directions are discussed in order to provide clinicians with a comprehensive diagnosis and treatment reference.
文章引用：邓求生, 韩猛. 化生性乳腺癌的研究进展[J]. 临床医学进展, 2025, 15(3): 1302-1307. https://doi.org/10.12677/acm.2025.153742

参考文献

[1] Polamraju, P., Haque, W., Cao, K., Verma, V., Schwartz, M., Klimberg, V.S., et al. (2020) Comparison of Outcomes between Metaplastic and Triple-Negative Breast Cancer Patients. The Breast, 49, 8-16. [Google Scholar] [CrossRef] [PubMed]
[2] El Zein, D., Hughes, M., Kumar, S., Peng, X., Oyasiji, T., Jabbour, H., et al. (2017) Metaplastic Carcinoma of the Breast Is More Aggressive than Triple-Negative Breast Cancer: A Study from a Single Institution and Review of Literature. Clinical Breast Cancer, 17, 382-391. [Google Scholar] [CrossRef] [PubMed]
[3] Tray, N., Taff, J. and Adams, S. (2019) Therapeutic Landscape of Metaplastic Breast Cancer. Cancer Treatment Reviews, 79, Article 101888. [Google Scholar] [CrossRef] [PubMed]
[4] 阙秀. 化生性乳腺癌[J]. 中国肿瘤临床, 1998, 25(9): 688-690.
[5] Luini, A., Aguilar, M., Gatti, G., Fasani, R., Botteri, E., Brito, J.A.D., et al. (2006) Metaplastic Carcinoma of the Breast, an Unusual Disease with Worse Prognosis: The Experience of the European Institute of Oncology and Review of the Literature. Breast Cancer Research and Treatment, 101, 349-353. [Google Scholar] [CrossRef] [PubMed]
[6] Lakhani, S.R., Ellis, I.O., Schnitt, S.J., et al. (2012) WHO Classification of Tumours of the Breast. IARC.
[7] Thomas, A., Douglas, E., Reis-Filho, J.S., Gurcan, M.N. and Wen, H.Y. (2023) Metaplastic Breast Cancer: Current Understanding and Future Directions. Clinical Breast Cancer, 23, 775-783. [Google Scholar] [CrossRef] [PubMed]
[8] Wargotz, E.S. and Norris, H.J. (1989) Metaplastic Carcinomas of the Breast. I. Matrix-Producing Carcinoma. Human Pathology, 20, 628-635. [Google Scholar] [CrossRef] [PubMed]
[9] Wargotz, E.S., Does, P.H. and Norris, H.J. (1989) Metaplastic Carcinomas of the Breast. II. Spindle Cell Carcinoma. Human Pathology, 20, 732-740. [Google Scholar] [CrossRef] [PubMed]
[10] Wargotz, E.S. and Norris, H.J. (1989) Metaplastic Carcinomas of the Breast. III. Carcinosarcoma. Cancer, 64, 1490-1499. [Google Scholar] [CrossRef] 
[11] WHO Classification of Tumours Editorial Board (2019) Breast Tumours. 5th Edition, IARC.
[12] Khade, S., Khera, S., Elhence, P. and Vishnoi, J.R. (2021) Metaplastic Breast Carcinoma with Extensive Osseous Differentiation. Autopsy Case Reports, 11, e2021331. [Google Scholar] [CrossRef] [PubMed]
[13] McMullen, E.R., Zoumberos, N.A. and Kleer, C.G. (2019) Metaplastic Breast Carcinoma: Update on Histopathology and Molecular Alterations. Archives of Pathology & Laboratory Medicine, 143, 1492-1496. [Google Scholar] [CrossRef] [PubMed]
[14] Schwartz, T.L., Mogal, H., Papageorgiou, C., Veerapong, J. and Hsueh, E.C. (2013) Metaplastic Breast Cancer: Histologic Characteristics, Prognostic Factors and Systemic Treatment Strategies. Experimental Hematology & Oncology, 2, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
[15] Khong, K., Zhang, Y., Tomic, M., Lindfors, K.K. and Aminololama-Shakeri, S. (2015) Aggressive Metaplastic Carcinoma of the Breast with Osteoclastic Giant Cells. Journal of Radiology Case Reports, 9, 11-19. [Google Scholar] [CrossRef] [PubMed]
[16] Leddy, R., Irshad, A., Rumboldt, T., Cluver, A., Campbell, A. and Ackerman, S. (2012) Review of Metaplastic Carcinoma of the Breast: Imaging Findings and Pathologic Features. Journal of Clinical Imaging Science, 2, Article 21. [Google Scholar] [CrossRef] [PubMed]
[17] Bian, T., Lin, Q., Wu, Z., Cui, C., Qi, C., Li, L., et al. (2016) Metaplastic Carcinoma of the Breast: Imaging and Pathological Features. Oncology Letters, 12, 3975-3980. [Google Scholar] [CrossRef] [PubMed]
[18] Zhou, X., Wu, X., Wang, L., et al. (2021) Metaplastic Breast Carcinoma: A Retrospective Study of 26 Cases. International Journal of Clinical and Experimental Pathology, 14, 355-362.
[19] Salih, A.M., Kakamad, F.H., Saeed, Y.A. and Muhialdeen, A.S. (2017) Metaplastic Breast Carcinoma with Osseous Differentiation: A Rare Case Report. International Journal of Surgery Case Reports, 34, 100-102. [Google Scholar] [CrossRef] [PubMed]
[20] Luo, K. and Wang, X. (2021) Bone in the Breast: A Case Report of a Metaplastic Breast Cancer with Osseous Differentiation. Radiology Case Reports, 16, 136-139. [Google Scholar] [CrossRef] [PubMed]
[21] Hasbay, B., Bolat, F.A., Aytac, H.O., Aslan, H. and Purbager, A. (2019) Metaplastic Carcinoma of the Breast: Analysis of 38 Cases from a Single Institute. Turkish Journal of Pathology, 36, 23-30. [Google Scholar] [CrossRef] [PubMed]
[22] Yan, Q., Deng, Y. and Zhang, Q. (2024) A Comprehensive Overview of Metaplastic Breast Cancer: Features and Treatments. Cancer Science, 115, 2506-2514. [Google Scholar] [CrossRef] [PubMed]
[23] Shah, V.V., Duncan, A.D., Jiang, S., Stratton, S.A., Allton, K.L., Yam, C., et al. (2021) Mammary-Specific Expression of Trim24 Establishes a Mouse Model of Human Metaplastic Breast Cancer. Nature Communications, 12, Article No. 5389. [Google Scholar] [CrossRef] [PubMed]
[24] Vranic, S. (2022) Comment on the Manuscript “Histological Subtype Is Associated with PD-L1 Expression and CD8+ T-Cell Infiltrates in Triple-Negative Breast Carcinoma” by Salisbury et al. (Ann Diagn Pathol 2022; 57: 151901, Annals of Diagnostic Pathology, 58, 151938. [Google Scholar] [CrossRef] 
[25] Okazaki, H., Mezawa, Y., Shi, Y., Sakimoto, M., Wang, Z., Ishizuka, A., et al. (2025) Expression of Lymphoid Enhancer‐Binding Factor 1 in Cancer‐Associated Fibroblasts Mediates Tumor Growth and Transdifferentiation toward Squamous Cell Carcinoma in Human Breast Cancer. Cancer Medicine, 14, e70627. [Google Scholar] [CrossRef] [PubMed]
[26] Weigelt, B., Eberle, C., Cowell, C.F., Ng, C.K.Y. and Reis-Filho, J.S. (2014) Metaplastic Breast Carcinoma: More than a Special Type. Nature Reviews Cancer, 14, 147-148. [Google Scholar] [CrossRef] [PubMed]
[27] Corso, G., Frassoni, S., Girardi, A., De Camilli, E., Montagna, E., Intra, M., et al. (2020) Metaplastic Breast Cancer: Prognostic and Therapeutic Considerations. Journal of Surgical Oncology, 123, 61-70. [Google Scholar] [CrossRef] [PubMed]
[28] Chen, I.C., Lin, C.H., Huang, C.S., Lien, H.C., Hsu, C., Kuo, W.H., et al. (2011) Lack of Efficacy to Systemic Chemotherapy for Treatment of Metaplastic Carcinoma of the Breast in the Modern Era. Breast Cancer Research and Treatment, 130, 345-351. [Google Scholar] [CrossRef] [PubMed]
[29] Hu, J., Zhang, H., Dong, F., Zhang, X., Wang, S., Ming, J., et al. (2021) Metaplastic Breast Cancer: Treatment and Prognosis by Molecular Subtype. Translational Oncology, 14, Article 101054. [Google Scholar] [CrossRef] [PubMed]
[30] Tseng, W.H. and Martinez, S.R. (2010) Metaplastic Breast Cancer: To Radiate or Not to Radiate? Annals of Surgical Oncology, 18, 94-103. [Google Scholar] [CrossRef] [PubMed]
[31] Lee, H., Jung, S., Ro, J.Y., Kwon, Y., Sohn, J.H., Park, I.H., et al. (2012) Metaplastic Breast Cancer: Clinicopathological Features and Its Prognosis. Journal of Clinical Pathology, 65, 441-446. [Google Scholar] [CrossRef] [PubMed]
[32] Abouharb, S. and Moulder, S. (2015) Metaplastic Breast Cancer: Clinical Overview and Molecular Aberrations for Potential Targeted Therapy. Current Oncology Reports, 17, Article No. 10. [Google Scholar] [CrossRef] [PubMed]
[33] McCart Reed, A.E., Kalaw, E., Nones, K., Bettington, M., Lim, M., Bennett, J., et al. (2019) Phenotypic and Molecular Dissection of Metaplastic Breast Cancer and the Prognostic Implications. The Journal of Pathology, 247, 214-227. [Google Scholar] [CrossRef] [PubMed]
[34] Takala, S., Heikkilä, P., Nevanlinna, H., Blomqvist, C. and Mattson, J. (2019) Metaplastic Carcinoma of the Breast: Prognosis and Response to Systemic Treatment in Metastatic Disease. The Breast Journal, 25, 418-424. [Google Scholar] [CrossRef] [PubMed]

为你推荐